Charles River Laboratories International, Inc. (CRL) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Charles River Laboratories International, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -69.93x | 928.90x | 25.52x | 22.77x | 48.47x | 33.98x |
| P/B Ratio | 3.19x | 2.76x | 3.37x | 3.72x | 7.48x | 5.85x |
| P/S Ratio | 2.51x | 2.36x | 2.93x | 2.78x | 5.35x | 4.23x |
| Profitability | ||||||
| Gross Margin | 30.5% | 32.9% | 36.4% | 36.8% | 37.7% | 36.7% |
| Operating Margin | 12.6% | 5.6% | 14.9% | 16.4% | 16.7% | 14.8% |
| Net Margin | -3.6% | 0.3% | 11.5% | 12.2% | 11.0% | 12.5% |
| EBITDA Margin | 22.7% | 14.3% | 25.0% | 24.8% | 23.2% | 26.3% |
| Liquidity | ||||||
| Current Ratio | 1.29x | 1.41x | 1.52x | 1.32x | 1.23x | 1.43x |
| Quick Ratio | 1.02x | 1.13x | 1.16x | 1.08x | 1.04x | 1.21x |
| Leverage | ||||||
| Debt/Equity | 0.97x | 0.79x | 0.85x | 1.04x | 1.26x | 1.02x |
YoY = year-over-year change. Source: FMP..